Frederic Sigoillot
0000-0002-8695-4838
Publication & Citation Trends
Publications
0 total
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter—Compounds with Novel Mechanisms from High-Throughput Screening Profiles OA
Cited by 5
Semantic Scholar
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance OA
Cited by 0
Semantic Scholar
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance OA
Cited by 63
Semantic Scholar
Reinstating targeted protein degradation with DCAF1 PROTACs in CRBN PROTAC resistant settings OA
Cited by 2
Semantic Scholar
Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control. OA
Cited by 22
Semantic Scholar
Cell adhesion molecule KIRREL1 is a feedback regulator of Hippo signaling recruiting SAV1 to cell-cell contact sites OA
Cited by 28
Semantic Scholar
Research Topics
RNA and protein synthesis mechanisms
(9)
Computational Drug Discovery Methods
(8)
Hearing, Cochlea, Tinnitus, Genetics
(7)
RNA modifications and cancer
(7)
Melanoma and MAPK Pathways
(7)
Affiliations
Novartis (Switzerland)
Boston Biomedical Research Institute
Harvard University
Wayne State University
Novartis (China)